NEW DELHI : In a move that could potentially pave the way for Pfizer and Johnson & Johnson’s covid-19 vaccines in India, the Centre on Tuesday said it would allow the granting of emergency licensure for vaccines that have received authorization in the US, UK, Europe, Japan or from the World Health Organization (WHO).The move comes at a time when India is facing a vaccine shortage as both Serum Institute of India and Bharat Biotech International struggle to scale up capacity of Covishield and Covaxin, respectively, to meet domestic demand even as the new wave of covid-19 takes daily new additions to record levels.Also Read | Why Bangladesh is flying high at 50On Monday, India added more than 160,000 new cases, taking its total active cases.